<DOC>
	<DOCNO>NCT02812355</DOCNO>
	<brief_summary>The RATIO Study multicenter , nationwide , randomize , control , single blind , unfunded trial n. 900 patient undergoing multivessel OPCAB ( ≥2 graft ) . This study design test patient undergo off-pump coronary artery bypass surgery hypothesis full ( high dose , 300 U/kg ) half ( low dose,150 U/kg ) heparinization different term thrombotic complication major perioperative bleeding event ( null hypothesis ) .</brief_summary>
	<brief_title>Randomized Anticoagulation Trial Opcab ( RATIO )</brief_title>
	<detailed_description>Off-pump coronary artery bypass grafting ( OPCAB ) establish alternative on-pump coronary artery bypass grafting ( CABG ) . OPCAB determine pro-coagulant state potentially deleterious graft patency , counterbalance adverse effect cardiopulmonary bypass coagulation occur CABG , last long one month . Therefore OPCAB systemic heparinization necessary prevent thrombotic complication transitory occlusion coronary artery graft . An internationally accepted standard intra-operative anticoagulation protocol OPCAB yet define , heparinization OPCAB highly variable practice . The intraoperative anticoagulation regimen adopt patient undergoing OPCAB may influence major postoperative outcome , bleeding , transfusion requirement , inflammatory response , myocardial ischemia graft patency , never object large-scale randomized control trial ( RCT ) . The 2 widespread intraoperative anticoagulation protocol OPCAB represent full ( 300 U/kg ) half ( 150 U/kg ) heparinization , target ACT range 200 sec &gt; 480 sec . Patients enrol study randomize receive full half heparinization 1:1 ratio use randomization schedule block site . Randomization take place operatory room anesthesiologist , blind surgeon .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Consecutive patient electively undergo multivessel OPCAB Acute coronary syndrome , ongoing double antiplatelets treatment ( second antiplatelet drug suspend 5 day surgery ) , ongoing intravenous heparin subcutaneous low molecular weight heparin , know coagulopathy , document liver disease , chronic renal failure ( creatinine ≥ 2 mg/dl ) previous renal transplantation surgery , previous cardiac surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>off-pump</keyword>
	<keyword>coronary artery bypass</keyword>
	<keyword>heparinization</keyword>
</DOC>